Craig Fraser's Net Worth
$148 Thousand
Who is Craig Fraser?
Craig Fraser does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include WINDTREE THERAPEUTICS INC /DE/, and Aegerion Pharmaceuticals, Inc..
SEC CIK
Craig Fraser's CIK is 0001557420
Past Insider Trading and Trends
2021 was Craig Fraser's most active year for acquiring shares with 14 total transactions. Craig Fraser's most active month to acquire stocks was the month of January. 2019 was Craig Fraser's most active year for disposing of shares, totalling 6 transactions. Craig Fraser's most active month to dispose stocks was the month of January. 2016 saw Craig Fraser paying a total of $15,381.00 for 252,363 shares, this is the most they've acquired in one year. In 2018 Craig Fraser cashed out on 15,560 shares for a total of $77,765.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
WINDTREE THERAPEUTICS INC /DE/ (WINT) Snapshot price: $2.79
President and CEOCraig Fraser owns 57,877 units of Common Stock which is worth $161,476.83. From 2016 to 2024 Craig Fraser acquired a total of 2,441,518 shares in WINDTREE THERAPEUTICS INC /DE/ at a cost of $90,789.27, Craig also disposed a total of 255,644 shares of WINDTREE THERAPEUTICS INC /DE/ equalling to $77,765.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 22
| |||
Form 4
| +4.51% | 2.5K |
$1.02 | $2,549.75 | 57.88K |
Sep 27
| |||
Form 4
| +4.73% | 2.5K |
$0.90 | $2,250.00 | 55.38K |
Sep 26
| |||
Form 4
| +654.31% | 45.87K |
—
|
—
| 52.88K |
Aug 23
| |||
Form 4
| +27.15% | 1.5K |
$1.77 | $2,649.69 | 7.01K |
Apr 26
| |||
Form 4
| +31.32% | 1.31K |
$1.89 | $2,485.35 | 5.51K |
Apr 25
| |||
Form 4
| -7.37% | -334.00 |
—
|
—
| 4.2K |
Feb 28
| |||
Form 4
| +1.12% | 2.5K |
$0.38 | $949.75 | 226.56K |
Jul 27
| |||
Form 4
| +1.13% | 2.5K |
$0.37 | $935.00 | 224.06K |
Jul 26
| |||
Form 4
| +2.07% | 4.5K |
$0.43 | $1,925.55 | 221.56K |
Jun 30
| |||
Form 4
| +3.33% | 7K |
$0.42 | $2,907.80 | 217.06K |
Jun 29
| |||
Form 4
| +0.96% | 2K |
$0.98 | $1,959.80 | 210.06K |
Mar 16
| |||
Form 4
| +1.46% | 3K |
$0.98 | $2,940.30 | 208.06K |
Mar 15
| |||
Form 4
| +437.39% | 166.9K |
—
|
—
| 205.06K |
Mar 4
| |||
Form 4
| +2.50% | 930 |
$1.60 | $1,488.00 | 38.16K |
Nov 19
| |||
Form 4
| +2.56% | 930 |
$1.61 | $1,497.30 | 37.23K |
Nov 18
| |||
Form 4
| +9.01% | 3K |
$1.90 | $5,700.00 | 36.3K |
Oct 22
| |||
Form 4
| +9.90% | 3K |
$1.91 | $5,730.00 | 33.3K |
Oct 19
| |||
Form 4
| +3.41% | 1K |
$2.09 | $2,092.00 | 30.3K |
Apr 16
| |||
Form 4
| +3.53% | 1K |
$2.24 | $2,239.90 | 29.3K |
Apr 15
| |||
Form 4
| +1.80% | 500 |
$2.57 | $1,285.00 | 28.3K |
Apr 6
| |||
Form 4
| +3.73% | 1K |
$2.58 | $2,579.90 | 27.8K |
Apr 5
| |||
Form 4
| +1.90% | 500 |
$2.46 | $1,229.35 | 26.8K |
Apr 1
| |||
Form 4
| +1.94% | 500 |
$2.32 | $1,159.95 | 26.3K |
Mar 31
| |||
Form 4
| +6.17% | 1.5K |
$3.25 | $4,875.00 | 25.8K |
Mar 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 22
| |||
Form 4
| +1.04% | 250 |
$6.56 | $1,639.88 | 24.3K |
Oct 28
| |||
Form 4
| +1.05% | 250 |
$5.83 | $1,456.25 | 24.05K |
Oct 9
| |||
Form 4
| +1.06% | 250 |
$5.17 | $1,292.50 | 23.8K |
Oct 7
| |||
Form 4
| +9.63% | 2.07K |
$7.25 | $15,000.25 | 23.55K |
May 22
| |||
Form 4/A
| -22.15% | -18.02K |
—
|
—
| 63.34K |
Mar 15
| |||
Form 4/A
| -3.12% | -2.62K |
—
|
—
| 81.36K |
Feb 7
| |||
Form 4
| +0.79% | 500 |
$4.10 | $2,050.00 | 63.59K |
Feb 10 - Feb 11
| |||
Form 4
| +0.96% | 600 |
$4.23 | $2,540.00 | 63.09K |
Feb 3 - Feb 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 19
| |||
Form 4
| -24.83% | -20.64K |
—
|
—
| 62.49K |
Mar 15
| |||
Form 4
| -1.01% | -851.00 |
—
|
—
| 83.13K |
Feb 7
| |||
Form 4
| -15.63% | -15.55K |
$5.00 | -$77,765.00 | 83.98K |
Dec 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 24
| |||
Form 4
| +0.35% | 350 |
—
|
—
| 99.53K |
Nov 21
| |||
Form 4
| +26,349.20% | 1.98M |
—
|
—
| 1.98M |
Nov 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
|
∞
| 7.5K |
$2.05 | $15,381.00 | 7.5K |
Oct 28
| |||
Form 4
|
∞
| 1.08K |
$1.93 | $2,080.54 | 1.08K |
Jun 30 - Jul 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aegerion Pharmaceuticals, Inc. No price found
Pres., US/Int. Comm. & Manuf.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||